News
Ab&B Bio-Tech soared as much as 169% in its trading debut in Hong Kong, after retail investors flocked to the Chinese vaccine ...
The IPO rules guarantee institutional investors 40 per cent of the offering, while leaving as little as 10 per cent for ...
The company plans to ship components made at its plant in Shenzhen to Hong Kong where robots for overseas clients would be ...
SINGAPORE] Interest in listing on US exchanges has surged among Singapore companies, with 13 initial public offerings (IPO) ...
During the first half of the year, Chinese mainland insurers have stepped up their holdings in Hong Kong-listed companies, a ...
Figma's IPO last week showed that there is high demand from Wall Street. Now, a crypto exchange called Bullish is planning to ...
Globally, Asian markets were mixed as participants awaited an announcement on whether the August 12 deadline for the US-China ...
Shares of China's Ab&B Bio-Tech gained nearly 170% on Monday, as the vaccine development firm debuted on the Hong Kong Stock Exchange after it raised $55 million in an initial public offering.
12h
The Chosun Ilbo on MSNHong Kong emerges as key hub for S. Korean UHNWIs seeking wealth securityHong Kong is rapidly emerging as a top destination for ultra-high-net-worth individuals (UHNWIs), those with over $30 million ...
With the ongoing reform at the STAR Market, research results are industrialized at a faster pace, growing into new economic ...
17h
BusinessWorld on MSNMPTC may further delay listing as debt, projects take priorityMETRO PACIFIC Tollways Corp. (MPTC) may further delay its plan to list on the stock exchange as the company focuses on debt reduction and completing ongoing road projects, according to its president.
In fact, Agibot has seen a string of executive exits this year. “Given where the robotics industry is today, personnel change ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results